samedan logo

 
 
spacer
home > news
INDUSTRY NEWS AND PRESS RELEASES
 

Mogrify enters research collaboration with the MRC Laboratory of Molecular Biology

Exploratory research project aims to develop novel protein expression systems via cell reprogramming

Cambridge, UK, 11 January 2021: Mogrify Limited (Mogrify®), a UK company aiming to transform the development of ex vivo cell therapies and pioneer the field of in vivo reprogramming therapies, and the MRC Laboratory of Molecular Biology (LMB), a world-class research laboratory dedicated to understanding important biological processes at the molecular level, today announced an exploratory research collaboration. The project aims to develop novel protein expression systems by leveraging recent advances in direct cell reprogramming to help improve the production of proteins which are not produced sufficiently well in existing expression systems. More>>

 
phone + 44 (0)1223 734154 Get In Contact Now
email info@mogrify.co.uk
web mogrify.co.uk
email 25 Cambridge Science Park Milton Rd, Milton, Cambridge CB4 0FW
 

Nova Biomedical FLEX2 Cell Culture Analyzer

Adds Sample Retain Capability

Waltham, MA–Nova Biomedical announces the addition of a Sample Retain Collector (SRC) for BioProfile FLEX2 cell culture analyzer. The FLEX2 automated cell culture analyzer measures up to 16 tests including pH, gases, metabolites, osmolality, cell density, and cell viability. A single FLEX2 analyzer with SRC and the previously introduced Online Sampler (OLS) module provides automated sampling and analysis of these key cell culture tests from as many as 10 bioreactors. This FLEX2 automation package saves hours of time versus manual sampling, analysis, sample storage, and after-hours cell culture monitoring. More>>

 
phone 781-894-0800
email info@novabio.com
web https://www.novabio.us/home.php
email 200 Prospect Street Waltham, MA 02454-9141 USA
 

Etihad Cargo Reports 50% Y-O-Y Rise in Pharma Shipments

Carrier operates across more than 1,050 pharma trade lanes and counts 54 dedicated pharma stations in its global network. Etihad Cargo, the cargo and logistics arm of Abu Dhabi-based Etihad Aviation Group, has reported a 50 per cent year-on-year rise in pharma shipments under its specialised PharmaLife product. More>>

 
phone +971 25990099
email CargoContact@etihad.ae
web https://www.etihadcargo.com/en-ae/index.html
email Building 549, Shoreham Road East, Heathrow Airport, Hounslow, Middlesex, TW6 3UA
 

The biotech company baseclick GmbH launched a new and highly efficient method for SARS-CoV-2 mutation analysis

The rapid spread of the newly emerging SARS-CoV-2 virus variant B.1.1.7 in Great Britain and other countries shows changes in the genome of the SARS-CoV-2 virus can lead to new biological properties. More>>

 
email info@baseclick.eu
web www.baseclick.eu
email baseclick GmbH Floriansbogen 2-4 D-82061 Neuried (Munich), Germany
 

Join Us In A New Free Webinar by Qloud

Our experience in qualifications has allowed us to identify the necessary improvements for the resolution of data integrity GAPs, and process optimization in regulated environments. More>>

 
phone +34 915 734 206
email we.are@qloudapp.com
web www.qloudapp.com
email Carretera de Fuencarral, 22. 28108 Alcobendas (Madrid)
 

PHASTAR Announces Investment by Charterhouse Capital Partners

Funding will Support Expansion of Statistics and Data Science Services and Geographic Reach

PHASTAR, a specialist biometrics clinical research organization (CRO) for clinical trials, announces an investment made by Charterhouse Capital Partners LLP, a long-established European private equity firm, which will support PHASTAR’s growth in biometrics and geographic expansion. Charterhouse is making its investment in partnership with PHASTAR’s Founder and CEO Kevin Kane, who remains a significant shareholder in the business. Kevin and the existing management team will continue to run, manage and operate the business on a day-to-day basis. More>>

 
phone +44 (0)20 7183 7062
email tellmemore@phastar.com
web www.phastar.com
email Unit 2, 2A Bollo Ln, Chiswick, London W4 5LE
 

Calyx Supports Breakthrough Therapy Approvals for Oncology Treatments

Calyx Medical Imaging and other eClinical services provide critical support for clinical development programs to deliver much-needed therapies to market

Calyx, the eClinical and regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, today announced that its Medical Imaging and other eClinical solutions supported half of the oncology treatments approved by the FDA as Breakthrough Therapies in the past two years. More>>

 
web www.calyx.ai/
 

BIOGEN TO LAUNCH PIONEERING STUDY TO DEVELOP DIGITAL BIOMARKERS OF COGNITIVE HEALTH USING APPLE WATCH AND IPHONE

January 11, 2021 at 7:30 AM EST

The study aims to identify digital biomarkers to help monitor cognitive performance and health including potentially detecting mild cognitive impairment, an early indicator of certain forms of dementia such as Alzheimer’s disease Cognitive health — the ability to think clearly, to learn and to remember — is an indicator of brain health and important to performing daily activities More>>

 
phone +44 1628 501 000
email ukreception@biogen.com
web https://www.biogen.com/
email Innovation House, 70 Norden Road, Maidenhead, Berkshire SL6 4AY
 

EQRx Scales Disruptive Model of Important New Medicines at Lower Prices with $500M Series B Financing

Funding accelerates development of late-stage cancer therapies, pipeline expansion and business growth Syndicate includes all Series A investors, preeminent life science and generalist funds, and market-leading health systems and payers More>>

 
email info@EQRx.com
web www.eqrx.com
 

Servier and X-Chem Announce Drug Discovery Collaboration in Neurological Diseases

Funding accelerates development of late-stage cancer therapies, pipeline expansion and business growth Syndicate includes all Series A investors, preeminent life science and generalist funds, and market-leading health systems and payers More>>

 
phone 781.419.6900
email info@x-chemrx.com
web www.x-chemrx.com
email 100 Beaver Street Waltham, MA 02453
 
 
spacer
News and Press Releases

SICK’s Super Versatile, Ready-Made Quality Control System

SICK’s newly-developed MQCS (Modular Quality Control System) is an “off the shelf”, multifunctional machine vision system, delivered as a ready-to-use package of hardware and pre-written software. Suitable for code reading, 2D or 3D inspection duties, the MQCS significantly reduces cost and development time needed to set up automated quality inspection and logistics applications in pharmaceutical production and packaging.
More info >>


White Papers

Bringing more control to temperature-sensitive logistics

UPS Supply Chain Solutions

By 2016, world sales of cold-chain drugs and biologics such as vaccines and blood plasma products will near $240 billion1. The increase has led to a surge in discussion about how to protect these products throughout the transportation logistics cycle. Industry experts are recommending that the term “cold chain” be eliminated from rules, guidance and best-practice documents. “Cold chain” now includes a broader spectrum of temperature ranges, such as controlled room temperature (CRT). This white paper focuses on the initial steps required to establish a temperature-sensitive supply chain.
More info >>

Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement